Last issue, we talked about finding your next NVIDIA — undervalued upcycled ingredients sitting in plain sight while the market obsessed over familiar names. But before you reallocate the entire portfolio, let's talk about what's already there.
Not everything celebrated is overhyped. Some ingredients have genuinely earned their place. The question isn't whether to include them — it's whether you're using them correctly, and at the right time.
This issue: three actives that belong in serious formulations, each with a different story for why 2026 is exactly the right moment.
Why Now?
The ingredient landscape is crowded. Every season brings new exosome variants, new regeneration actives, new "NAD+-inspired" longevity claims. Noise levels are high.
In that environment, ingredients that can point to robust, independently verified science — whether from peer-reviewed publication, high-purity clinical data, or mechanistic clarity others can't match — stand apart. Here's the shortlist.
1. Natori Exobiome LB — 2026 Global SCI journal update
Exobiome LB has been in the market as a postbiotic active: Lactobacillus-derived extracellular vesicles (EVs), averaging 100.5 nm in particle size — approximately 300× smaller than a skin pore. Good technology. Biologically coherent. But without independent academic validation, it's been easy to lump into the broader "postbiotic" noise.
That changed in 2026.
Natori Exobiome LB was published in Biomedicine & Pharmacotherapy (Vol. 199, Article 119457 — Open Access CC BY 4.0). The authors are researchers from the Medical University of Gdansk (Poland) and the University of Palermo (Italy), working independently of the supplier. It is the first indexed, peer-reviewed publication on this ingredient.
What the paper demonstrates (in vitro: HaCaT keratinocytes + HDF fibroblasts):
- Metabolic activity: statistically significant increase at 1.25–2.5% v/v (p<0.05)
- Wound closure: approximately 4 hours faster than control at 1.25% v/v (p<0.0001)
- Oxidative stress: significant intracellular ROS reduction in fibroblasts at 1% v/v (p<0.05)
- Anti-senescence: downregulation of p21 and 53BP1 senescence markers in keratinocytes (p<0.01)
Formulation note: All published findings are in vitro. The paper explicitly states that stratum corneum penetration was not tested. This is rigorous in vitro science — not clinical proof — positioned accordingly. Add to the aqueous phase below 60°C. Recommended usage: 1.0–5.0%.
For formulators who've been holding off on postbiotic EV actives pending independent scientific validation: that benchmark has now been cleared.
2. Natori PDRN — The Standard, For Good Reason
Some ingredients stay at the top because nothing has displaced them. PDRN (polydeoxyribonucleotide) is one of those.
Natori PDRN 95 (Sodium DNA, 95%+ purity, farmed salmon-derived) remains one of the most data-dense regeneration actives available — particularly at a purity level that separates it from most competing sources (typically 85–90%).
Clinically established data:
- Wound healing: 96% wound closure at 0.1% / 24 hours
- Barrier: FLG mRNA expression +287% (filaggrin, key to barrier integrity)
- Moisturization: AQP3 mRNA +227% post-UVB (aquaporin-3, water transport)
- Anti-inflammatory: nitric oxide inhibition ×3.6 reduction at 10%
- Brightening: tyrosinase inhibition (confirmed via DPPH antioxidant assay)
- Safety: 33-person clinical patch test, Korea Institute of Dermatological Sciences — non-irritating
The purity differential has formulation implications beyond marketing copy. Higher purity means lower off-odor and a cleaner sensory profile — a real-world processing advantage.
Recommended usage: 0.1–10% (1,000 ppm = 0.1% PDRN 95 / 1.0% PDRN 10L).
If PDRN isn't part of your regeneration brief yet, the data above is your starting point. If it is — this is your reference sheet.
3. WRINKLEZERO — Cellular Longevity, Without the Stability Headache
The longevity skincare category has grown fast — and so has the volume of NAD+-adjacent claims. The conceptual appeal is real: cellular energy restoration, mitochondrial health, addressing intrinsic aging at the metabolic level rather than the surface. The execution problem is equally real: NAD+ and many of its derivatives are notoriously unstable in formulation. Heat, pH shifts, and oxidation degrade activity before the product reaches the consumer. Getting meaningful NAD+ delivery into a stable finished formula is a genuine technical challenge the industry has not fully solved.
WRINKLEZERO (Vaccinium Angustifolium Fruit Extract, Brassica Oleracea Italica Extract, Cynara Scolymus Leaf Extract — blueberry, broccoli, artichoke) approaches the same underlying biology through a different entry point: mitophagy activation.
Mitophagy is the cell's selective clearance mechanism for damaged mitochondria. When functioning correctly, it removes dysfunctional mitochondria and allows healthier ones to restore ATP production and membrane potential — the cellular energy that declining skin biology loses over time. WRINKLEZERO's plant extract blend activates this pathway, with documented downstream effects including:
- Inhibition of MMP-1 and MMP-3 (the metalloproteinases primarily responsible for collagen and elastin breakdown)
- Increased Collagen I production
- Reduced cellular senescence markers
- Restored mitochondrial membrane potential and ATP levels (in vitro)
In a 4-week clinical study, a cream containing 2% WRINKLEZERO was applied twice daily. Assessments were conducted at the 2-week and 4-week marks across the following parameters:
- Anti-wrinkle: forehead wrinkle depth, glabella wrinkles, under-eye wrinkles, nasolabial fold depth
- Firming: overall facial skin firmness
- Lifting: inclination of the corner of the lip
Improvements were visible from week 2 and continued to progress through week 4. A 31-person skin irritation patch test confirmed non-irritating performance over 24 hours. In-vitro cell viability testing on human fibroblasts additionally confirmed the ingredient's safety profile at the recommended use level.
The formulation angle: WRINKLEZERO is a water-soluble plant complex. It does not carry the oxidative instability of nicotinamide-based longevity actives. For formulators working in the cellular longevity space who have encountered NAD+ stability issues — this is the mechanistically coherent, formulation-stable alternative.
Recommended usage: 2%.
What This Looks Like in Practice
These three ingredients don't compete. They stack across distinct biological levels:
- Exobiome LB (1.0–2.5%): Postbiotic microbiome support, anti-senescence, tissue repair signalling
- PDRN (0.1–1.0%): Barrier recovery, brightening, wound healing, anti-inflammatory
- WRINKLEZERO (2%): Mitophagy activation, mitochondrial energy restoration, collagen matrix support
Together, they address microbiome-level, extracellular matrix-level, and intracellular energy metabolism — without ingredient redundancy. A genuine full-stack brief.
Ready to Sample?
Technical datasheets and samples for Natori Exobiome LB, Natori PDRN, and WRINKLEZERO are available through MAHA Asia. If you want to pressure-test the data before committing to formulation, that's exactly what our technical team is here for.